Companies House true 2024-03-12 2025-03-26 false 15556635 uk-bus:Director1 2024-03-12 2025-03-26 15556635 uk-bus:Director2 2024-03-12 2025-03-26 15556635 2024-03-12 2025-03-26 15556635 2025-03-26 15556635 uk-bus:EntityHasNeverTraded 2024-03-12 2025-03-26 15556635 uk-bus:FRS102 2024-03-12 2025-03-26 15556635 uk-bus:FullAccounts 2024-03-12 2025-03-26 15556635 uk-bus:AuditExempt-NoAccountantsReport 2024-03-12 2025-03-26 15556635 uk-bus:OrdinaryShareClass1 2024-03-12 2025-03-26 15556635 uk-bus:OrdinaryShareClass2 2024-03-12 2025-03-26 15556635 uk-bus:OrdinaryShareClass3 2024-03-12 2025-03-26 15556635 uk-bus:PreferenceShareClass1 2024-03-12 2025-03-26 15556635 uk-bus:PreferenceShareClass2 2024-03-12 2025-03-26 15556635 uk-bus:PreferenceShareClass3 2024-03-12 2025-03-26 15556635 uk-core:ShareCapitalPreferenceShares 2025-03-26 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 15556635

NANJING MEDICAL AND PHARMACEUTICAL CO., LTD

Dormant Accounts

26 March 2025

NANJING MEDICAL AND PHARMACEUTICAL CO., LTD Registered Number 15556635

Balance Sheet as at 26 March 2025

2025
£
Called up share capital not paid
1000
Net assets
1000
Issued share capital
1000 Ordinary Shares of £ 1 each 1000
Total Shareholder funds
1000

STATEMENTS

  1. For the year ending 26 March 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 26 March 2025

And signed on their behalf by:
Qaria MAJJID AHMED SALEH, Director